Feed BNTX
BN

BioNTech

BNTX · NASDAQ

$91.83 -0.43% (-$0.40)
1M +0.95%
Market Cap 20.3B €
P/E Ratio -
Div. Yield -
ROE 3.04%

Bulios Fair Price

$103.3

12.5% upside

Current Price

$91.83

Undervalued Fair Value Overvalued
Valuation
50 /100
Fair
P/B 1.10x
P/S 6.45x
EV/EBITDA N/A
Growth
0 /100
Declining
FCF growth 72.67%
Book val. growth 1.42%
Rev. growth 45.80%
Profitability
20 /100
Weak
Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor
ROE 0.00%
ROA 0.00%
Asset turnover 0.15x
Debt
45 /100
Moderate
Current ratio 7.12x
Int. coverage -49.09x
Net debt/EBITDA 95.33x
Stability
8 /100
Unstable
Rev. volatility 39.57%
EPS volatility 57.07%
Profitable years 0
Ask StockBot about BNTX
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Ugur Sahin

Employees

7,807

Headquarters

Mainz

Upcoming events

04 AUG

Earnings

Upcoming earnings report

12d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.